A Clinical Trial on Efficacy and Safety for Lobaplatin and Gemcitabine in Combination With Docetaxel in the Second-line Treatments on Advanced Osteosarcoma

Clinical trial NCT02099396 · UNKNOWN

Trial details

NCT number: NCT02099396
Sponsor: China Association of Osteosarcoma Chemotherapy
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Lobaplatin and Gemcitabine in Combination, Second-line Treatments on Advanced Osteosarcoma

Start date: 2014-04-01
Primary completion: 2016-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.